Search Results 391-400 of 16386 for monoclonal antibody

1. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant ...

2. Thyroid Cancer Clinical Trials

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as ...

3. Medication overuse headaches - Diagnosis and treatment - Mayo Clinic

   If you have a history of migraine, your health care provider might suggest an injection of a CGRP monoclonal antibody such as erenumab (Aimovig) ...

4. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

5. Trial of Sequential Treatment of Multiple Myeloma with Antibody Therapy - Mayo Clinic

   ≥ Grade 3 neuropathy and/or POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes).

6. Clinical trials - Oncology (Medical)

   Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

7. Infliximab-dyyb (intravenous route, subcutaneous route) - Mayo Clinic

   This medicine is a monoclonal antibody that works on the immune system. This medicine is available only with your doctor's prescription. This product is ...

8. Select thyroid clinical trials at Mayo Clinic

   ... monoclonal antibody with the goal of decreasing TSH receptor antibody levels by 70% to 80%. Enrolled patients will be evaluated jointly by Mayo Clinic ...

9. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   ... monoclonal antibodies. The dose escalation phase of the study (50, 140, 450 ... She explains that while proteasome inhibitors, immune modulatory drugs and CD38 ...

10. Behind The Scenes, Pharmacists Play Key Role In Clinical Research - News Archive

    One of the clinical trials involves a study to evaluate the use of an investigational device to administer ipilimumab, a monoclonal antibody medication, ...